What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Myocardial infarction
Internal medicine, Cardiology, Myocardial infarction, Surgery and Percutaneous coronary intervention are his primary areas of study.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
His study explores the link between Cardiology and topics such as Hazard ratio that cross with problems in Unstable angina.
His Myocardial infarction research integrates issues from Platelet aggregation inhibitor, Ejection fraction, Stroke, Clinical endpoint and Drug.
His studies deal with areas such as Meta-analysis, Left Main Coronary Artery Stenosis, Stent thrombosis and Nephropathy as well as Surgery.
His Percutaneous coronary intervention research is multidisciplinary, relying on both Thrombolysis, Clinical trial, Conventional PCI and Multicenter trial.
His most cited work include:
- Large-scale association analysis identifies new risk loci for coronary artery disease (1172 citations)
- Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis (1029 citations)
- Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial (864 citations)
What are the main themes of his work throughout his whole career to date?
Hyo-Soo Kim mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Endocrinology.
His work on Revascularization, Clopidogrel, Artery and Angioplasty as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines.
His Myocardial infarction study combines topics in areas such as Diabetes mellitus, Clinical endpoint and Ejection fraction.
The study incorporates disciplines such as Conventional PCI and Acute coronary syndrome in addition to Percutaneous coronary intervention.
Hyo-Soo Kim studies Randomized controlled trial which is a part of Surgery.
He most often published in these fields:
- Internal medicine (65.65%)
- Cardiology (45.73%)
- Myocardial infarction (30.69%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (65.65%)
- Cardiology (45.73%)
- Myocardial infarction (30.69%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI are his primary areas of study.
His work on Hazard ratio, Coronary artery disease, Revascularization and Drug-eluting stent as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science.
His research in Revascularization intersects with topics in Diabetes mellitus and Cardiogenic shock.
His Myocardial infarction study integrates concerns from other disciplines, such as Stroke, Clinical endpoint and Propensity score matching.
His biological study spans a wide range of topics, including Stent, Surgery, Lower risk and Acute coronary syndrome.
As part of the same scientific family, Hyo-Soo Kim usually focuses on Conventional PCI, concentrating on Randomized controlled trial and intersecting with Meta-analysis.
Between 2017 and 2021, his most popular works were:
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting (80 citations)
- Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics (65 citations)
- Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Myocardial infarction
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI.
All of his Internal medicine and Hazard ratio, Coronary artery disease, Acute coronary syndrome, Prasugrel and Clopidogrel investigations are sub-components of the entire Internal medicine study.
His Cardiology research incorporates elements of Stroke, Incidence and Drug.
In Myocardial infarction, Hyo-Soo Kim works on issues like Clinical endpoint, which are connected to Urology.
His study in Percutaneous coronary intervention is interdisciplinary in nature, drawing from both Platelet aggregation inhibitor, Stent and ST segment.
Hyo-Soo Kim has included themes like Artery, Randomized controlled trial, Intensive care medicine, Pharmacotherapy and Aspirin in his Conventional PCI study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
